Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 05/12/15 → 05/11/16 |
Funding
- Pfizer Incorporated: $5,000.00
A Phase 1b, Double-Blinded, Placebo-Controlled, Randomized Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of PF-06342674 (RN168) in Subjects with Mulitple Sclerosis (MS)
- Coyle, Patricia K (PI)
- Kowalska, Agnieszka (CoPI)
- Sibony, Patrick (CoPI)
- Melville, Patricia (CoPI)
Project: Research